Literature DB >> 29929450

Myalgic encephalomyelitis/chronic fatigue syndrome and the biopsychosocial model: a review of patient harm and distress in the medical encounter.

Keith J Geraghty1, Charlotte Blease2.   

Abstract

Objective: Despite the growing evidence of physiological and cellular abnormalities in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS), there has been a strong impetus to tackle the illness utilizing a biopsychosocial model. However, many sufferers of this disabling condition report distress and dissatisfaction following medical encounters. This review seeks to account for this discord.
Methods: A narrative review methodology is employed to synthesize the evidence for potential iatrogenesis.
Results: We identify seven potential modalities of iatrogenesis or harm reported by patients:difficulties in reaching an acceptable diagnosis;misdiagnosis, including of other medical and psychological conditions;difficulties in accessing the sick role, medical care and social support;high levels of patient dissatisfaction with the quality of medical care;negative responses to controversial therapies (cognitive behavioral therapy and graded exercise therapy);challenges to the patient narrative and experience;psychological harm (individual and collective distress).
Conclusion: The biopsychosocial framework currently applied to ME/CFS is too narrow in focus and fails to adequately incorporate the patient narrative. Misdiagnosis, conflict, and harm are observable outcomes where doctors' and patients' perspectives remain incongruent. Biopsychosocial practices should be scrutinized for potential harms. Clinicians should consider adopting alternative patient-centred approaches.Implications for rehabilitationPatients with ME/CFS may report or experience one or more of the modalities of harms and distress identified in this review.It is important health and rehabilitation professionals seek to avoid and minimize harms when treating or assisting ME/CFS patients.There are conflicting models of ME/CFS; we highlight two divergent models, a biopsychosocial model and a biomedical model that is preferred by patients.The 'biopsychosocial framework' applied in clinical practice promotes treatments such as cognitive behavioral therapy and exercise therapy, however, the evidence for their success is contested and many patients reject the notion their illness is perpetuated by dysfunctional beliefs, personality traits, or behaviors.Health professionals may avoid conflict and harm causation in ME/CFS by adopting more concordant 'patient-centred' approaches that give greater prominence to the patient narrative and experience of illness.

Entities:  

Keywords:  Chronic fatigue syndrome; biopsychosocial model; doctor–patient relationship; harm; iatrogenesis; treatment

Year:  2018        PMID: 29929450     DOI: 10.1080/09638288.2018.1481149

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  11 in total

Review 1.  Glial Activation and Expression of the Serotonin Transporter in Chronic Fatigue Syndrome.

Authors:  Mami Noda; Masataka Ifuku; Md Shamim Hossain; Toshihiko Katafuchi
Journal:  Front Psychiatry       Date:  2018-11-16       Impact factor: 4.157

2.  Chronic fatigue syndrome and an illness-focused approach to care: controversy, morality and paradox.

Authors:  Michael Sharpe; Monica Greco
Journal:  Med Humanit       Date:  2019-06-18

3.  Post-Exertional Malaise Is Associated with Hypermetabolism, Hypoacetylation and Purine Metabolism Deregulation in ME/CFS Cases.

Authors:  Neil R McGregor; Christopher W Armstrong; Donald P Lewis; Paul R Gooley
Journal:  Diagnostics (Basel)       Date:  2019-07-04

Review 4.  Treating medically unexplained symptoms via improving access to psychological therapy (IAPT): major limitations identified.

Authors:  Keith Geraghty; Michael J Scott
Journal:  BMC Psychol       Date:  2020-02-05

Review 5.  An Association of Serotonin with Pain Disorders and Its Modulation by Estrogens.

Authors:  Stephania Paredes; Santiago Cantillo; Kenneth D Candido; Nebojsa Nick Knezevic
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

6.  Self-Reported Time to Diagnosis and Proportions of Rediagnosis in Female Patients with Chronic Conditions in Australia: A Cross-sectional Survey.

Authors:  Lea Merone; Komla Tsey; Darren Russell; Andrew Daltry; Cate Nagle
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-09-12

7.  Medical School Education on Myalgic Encephalomyelitis.

Authors:  Nina Muirhead; John Muirhead; Grace Lavery; Ben Marsh
Journal:  Medicina (Kaunas)       Date:  2021-05-28       Impact factor: 2.430

Review 8.  Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Lily Chu; Meghan Elliott; Eleanor Stein; Leonard A Jason
Journal:  Healthcare (Basel)       Date:  2021-05-25

9.  Striking the balance with epistemic injustice in healthcare: the case of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Authors:  Eleanor Alexandra Byrne
Journal:  Med Health Care Philos       Date:  2020-09

10.  Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?

Authors:  Lawrence B Afrin; Tania T Dempsey; Leonard B Weinstock
Journal:  Vaccines (Basel)       Date:  2022-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.